Diagnostic accuracy study of multiplex PCR for detecting tuberculosis drug resistance

Journal of Infection

Volumn 71, Issue 2, 2015, Pages 220-230

  Molina Moya, B ^a,b   Lacoma, A ^a,b   Prat, C ^a,b   Pimkina, E ^c   Diaz, J ^a,b   Garcia Sierra N ^a   Haba, L ^a   Maldonado, J ^d   Samper, S ^b,e,f   Ruiz Manzano, J ^a,b   Ausina, V ^a,b   Dominguez, J ^a,b  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c VILNIUS UNIVERSITY   (Lithuania)

^d Hospital Serveis Clinics   (Spain)

^e INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^f HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

Fluoroquinolones; Isoniazid; Molecular resistance detection; Multiplex real time PCR; Rifampicin; Second line injectable drugs; Tuberculosis

Indexed keywords

AMIKACIN; CAPREOMYCIN; ISONIAZID; KANAMYCIN; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANALYTICAL EQUIPMENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; MULTIPLEX POLYMERASE CHAIN REACTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION SYSTEM; PYROSEQUENCING; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SPUTUM CULTURE; TUBERCULOSIS; COMPARATIVE STUDY; DRUG RESISTANCE; EVALUATION STUDY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; PROCEDURES; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE; HUMANS; MICROBIAL SENSITIVITY TESTS; MULTIPLEX POLYMERASE CHAIN REACTION; MYCOBACTERIUM TUBERCULOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84937516929     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2015.03.011     Document Type: Article

References (43)

1. World Health Organization Global tuberculosis control. (WHO/HTM/TB/2013.11). Geneva Switzerland 2013.
2. Musser J.M., Kapur V., Williams D.L., Kreiswirth B.N., van Soolingen D., van Embden J.D. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. J Infect Dis 1996 Jan, 173(1):196-202. PubMed PMID: 8537659.
3. Zhang Y., Heym B., Allen B., Young D., Cole S. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 1992 Aug 13, 358(6387):591-593. PubMed PMID: 1501713.
4. Zhang Y., Yew W.W. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2009 Nov, 13(11):1320-1330. PubMed PMID: 19861002.
5. Telenti A., Imboden P., Marchesi F., Lowrie D., Cole S., Colston M.J., et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 1993 Mar 13, 341(8846):647-650. PubMed PMID: 8095569.
6. Ramaswamy S., Musser J.M. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 1998, 79(1):3-29. PubMed PMID: 10645439.
7. Takiff H.E., Salazar L., Guerrero C., Philipp W., Huang W.M., Kreiswirth B., et al. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob Agents Chemother 1994 Apr, 38(4):773-780. PubMed PMID: 8031045.
8. Maruri F., Sterling T.R., Kaiga A.W., Blackman A., van der Heijden Y.F., Mayer C., et al. A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system. J Antimicrob Chemother 2012 Apr, 67(4):819-831. PubMed PMID: 22279180.
9. Maus C.E., Plikaytis B.B., Shinnick T.M. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2005 Aug, 49(8):3192-3197. PubMed PMID: 16048924.
10. Georghiou S.B., Magana M., Garfein R.S., Catanzaro D.G., Catanzaro A., Rodwell T.C. Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review. PLoS One 2012, 7(3):e33275. PubMed PMID: 22479378.
11. Zaunbrecher M.A., Sikes R.D., Metchock B., Shinnick T.M., Posey J.E. Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci U. S. A 2009 Nov 24, 106(47):20004-20009. PubMed PMID: 19906990.
12. Drobniewski F., Nikolayevskyy V., Maxeiner H., Balabanova Y., Casali N., Kontsevaya I., et al. Rapid diagnostics of tuberculosis and drug resistance in the industrialized world: clinical and public health benefits and barriers to implementation. BMC Med 2013, 11:190. PubMed PMID: 23987891. Pubmed Central PMCID: 3765611.
13. Garcia-Sierra N., Lacoma A., Prat C., Haba L., Maldonado J., Ruiz-Manzano J., et al. Pyrosequencing for rapid molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 2011 Oct, 49(10):3683-3686.
14. Lacoma A., Garcia-Sierra N., Prat C., Maldonado J., Ruiz-Manzano J., Haba L., et al. GenoType MTBDRsl for molecular detection of second-line and ethambutol resistance in Mycobacterium tuberculosis strains and clinical samples. J Clin Microbiol 2012 Nov 9, 50(1):30-36. PubMed PMID: 22075597.
15. Lacoma A., Garcia-Sierra N., Prat C., Ruiz-Manzano J., Haba L., Roses S., et al. GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples. J Clin Microbiol 2008 Nov, 46(11):3660-3667. PubMed PMID: 18784319.
16. Molina-Moya B., Lacoma A., Prat C., Diaz J., Dudnyk A., Haba L., et al. AID TB resistance line probe assay for rapid detection of resistant Mycobacterium tuberculosis in clinical samples. JInfect 2015 Apr, 70(4):400-408. PubMed PMID: 25305498. 10.1016/j.jinf.2014.09.010.
17. Molina-Moya B., Latorre I., Lacoma A., Prat C., Domínguez J. Recent advances in tuberculosis diagnosis: IGRAs and molecular biology. Curr Treat Options Infect Dis 2014 Oct, 6(4):377-391. 10.1007/s40506-014-0034-0.
18. Chang K., Lu W., Wang J., Zhang K., Jia S., Li F., et al. Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis. J Infect 2012 Jun, 64(6):580-588. PubMed PMID: 22381459.
19. Espasa M., Gonzalez-Martin J., Alcaide F., Aragon L.M., Lonca J., Manterola J.M., et al. Direct detection in clinical samples of multiple gene mutations causing resistance of Mycobacterium tuberculosis to isoniazid and rifampicin using fluorogenic probes. J Antimicrob Chemother 2005 Jun, 55(6):860-865. PubMed PMID: 15879493.
20. Ruiz M., Torres M.J., Llanos A.C., Arroyo A., Palomares J.C., Aznar J. Direct detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis in auramine-rhodamine-positive sputum specimens by real-time PCR. J Clin Microbiol 2004 Apr, 42(4):1585-1589. PubMed PMID: 15071008. Pubmed Central PMCID: 387553.
21. Kent P.T.K., G.P. Public health mycobacteriology-a guide for the level III laboratory 1985, U.S. Department of Health and Human Services, U.S. Government Printing Office, Washington, D.C., [Atlanta, Ga].
22. Isenberg H.D. Clinical microbiology procedures handbook 2007, 4300. 2nd update, ASM Press, Washington. H.D. Isenberg (Ed.).
23. Tessema B., Beer J., Emmrich F., Sack U., Rodloff A.C. Rate of recovery of Mycobacterium tuberculosis from frozen acid-fast-bacillus smear-positive sputum samples subjected to long-term storage in Northwest Ethiopia. J Clin Microbiol 2011 Jul, 49(7):2557-2561. PubMed PMID: 21562105.
24. Pfyffer G.E., Bonato D.A., Ebrahimzadeh A., Gross W., Hotaling J., Kornblum J., et al. Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media. J Clin Microbiol 1999 Oct, 37(10):3179-3186. PubMed PMID: 10488174. Pubmed Central PMCID: 85522.
25. World Health Organization Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs (WHO/HTM/TB/2008.392) 2008, Geneva Switzerland.
26. Lin S.Y., Desmond E., Bonato D., Gross W., Siddiqi S. Multicenter evaluation of bactec MGIT 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex. J Clin Microbiol 2009 Nov, 47(11):3630-3634. PubMed PMID: 19741086. Pubmed Central PMCID: 2772628.
27. Rodrigues C., Jani J., Shenai S., Thakkar P., Siddiqi S., Mehta A. Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the bactec MGIT 960 System. Int J Tuberc Lung Dis 2008 Dec, 12(12):1449-1455. PubMed PMID: 19017456.
28. Coll P., Aragon L.M., Alcaide F., Espasa M., Garrigo M., Gonzalez J., et al. Molecular analysis of isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates recovered from Barcelona. Microb Drug Resist 2005 Summer, 11(2):107-114. PubMed PMID: 15910223.
29. Bossuyt P.M., Reitsma J.B., Bruns D.E., Gatsonis C.A., Glasziou P.P., Irwig L.M., et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. The standards for reporting of diagnostic accuracy group. Croat Med J 2003 Oct, 44(5):639-650. PubMed PMID: 14515429.
30. Wada T., Maeda S., Tamaru A., Imai S., Hase A., Kobayashi K. Dual-probe assay for rapid detection of drug-resistant Mycobacterium tuberculosis by real-time PCR. J Clin Microbiol 2004 Nov, 42(11):5277-5285. PubMed PMID: 15528726. Pubmed Central PMCID: 525196.
31. Shekar S., Yeo Z.X., Wong J.C., Chan M.K., Ong D.C., Tongyoo P., et al. Detecting novel genetic variants associated with isoniazid-resistant Mycobacterium tuberculosis. PLoS One 2014, 9(7):e102383. PubMed PMID: 25025225. Pubmed Central PMCID: 4099304.
32. Chakravorty S., Aladegbami B., Thoms K., Lee J.S., Lee E.G., Rajan V., et al. Rapid detection of fluoroquinolone-resistant and heteroresistant Mycobacterium tuberculosis by use of sloppy molecular beacons and dual melting-temperature codes in a real-time PCR assay. J Clin Microbiol 2011 Mar, 49(3):932-940. PubMed PMID: 21191047. Pubmed Central PMCID: 3067712.
33. Liu Q., Luo T., Li J., Mei J., Gao Q. Triplex real-time PCR melting curve analysis for detecting Mycobacterium tuberculosis mutations associated with resistance to second-line drugs in a single reaction. J Antimicrob Chemother 2013 May, 68(5):1097-1103. PubMed PMID: 23288402. Pubmed Central PMCID: 3625432.
34. van Doorn H.R., An D.D., de Jong M.D., Lan N.T., Hoa D.V., Quy H.T., et al. Fluoroquinolone resistance detection in Mycobacterium tuberculosis with locked nucleic acid probe real-time PCR. Int J Tuberc Lung Dis 2008 Jul, 12(7):736-742. PubMed PMID: 18544197.
35. Alangaden G.J., Kreiswirth B.N., Aouad A., Khetarpal M., Igno F.R., Moghazeh S.L., et al. Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis. Antimicrob Agents Chemother 1998 May, 42(5):1295-1297. PubMed PMID: 9593173.
36. Richter E., Rusch-Gerdes S., Hillemann D. Drug-susceptibility testing in TB: current status and future prospects. Expert Rev Respir Med 2009 Oct, 3(5):497-510. PubMed PMID: 20477339.
37. Rodwell T.C., Valafar F., Douglas J., Qian L., Garfein R.S., Chawla A., et al. Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations. J Clin Microbiol 2014 Mar, 52(3):781-789. PubMed PMID: 24353002. Pubmed Central PMCID: 3957771.
38. Engstrom A., Morcillo N., Imperiale B., Hoffner S.E., Jureen P. Detection of first- and second-line drug resistance in Mycobacterium tuberculosis clinical isolates by pyrosequencing. J Clin Microbiol 2012 Jun, 50(6):2026-2033. PubMed PMID: 22461677.
39. Blaschitz M., Hasanacevic D., Hufnagl P., Hasenberger P., Pecavar V., Meidlinger L., et al. Real-time PCR for single-nucleotide polymorphism detection in the 16S rRNA gene as an indicator for extensive drug resistance in Mycobacterium tuberculosis. J Antimicrob Chemother 2011 Jun, 66(6):1243-1246. PubMed PMID: 21393159.
40. Streicher E.M., Bergval I., Dheda K., Bottger E.C., Gey van Pittius N.C., Bosman M., et al. Mycobacterium tuberculosis population structure determines the outcome of genetics-based second-line drug resistance testing. Antimicrob Agents Chemother 2012 May, 56(5):2420-2427. PubMed PMID: 22330913. Pubmed Central PMCID: 3346650.
41. Steingart K.R., Schiller I., Horne D.J., Pai M., Boehme C.C., Dendukuri N. Xpert(R) MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane database Syst Rev 2014, 1. CD009593. PubMed PMID: 24448973.
42. Garcia de Viedma D. Rapid detection of resistance in Mycobacterium tuberculosis: a review discussing molecular approaches. Clin Microbiol Infect 2003 May, 9(5):349-359. PubMed PMID: 12848747.
43. Liu F., Hu Y., Wang Q., Li H.M., Gao G.F., Liu C.H., et al. Comparative genomic analysis of Mycobacterium tuberculosis clinical isolates. BMC genomics 2014, 15:469. PubMed PMID: 24923884. Pubmed Central PMCID: 4070564.